Why Verve Therapeutics Zoomed 40% Higher This Week

Is Iovance Biotherapeutics (IOVA) the Most Promising Penny Stock According to Analysts?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Plus Therapeutics Appoints Kyle Guse to Board

Tempest Therapeutics Inc - Expects $1.5 Million in Cash Expenditures - SEC Filing

Regeneron to Reassess Strategy for Retinal Condition Treatment After FDA Rejects Dosing Plan

Regeneron Provides Update on Eylea Hd® (Aflibercept) Injection 8 Mg Supplemental Biologics License Application

Regeneron Pharmaceuticals Inc - Crl Does Not Identify Safety or Efficacy Issues With Eylea Hd

Predictive Oncology Inc - Denies Entering Merger Agreement With Renovaro - SEC Filing

Recursion Pharmaceuticals (NasdaqGS:RXRX) Taps Real-World Data With HealthVerity Licensing Deal

BRIEF-Dupixent Approved In US As First New Targeted Therapy In Over Decade For Chronic Spontaneous Urticaria

Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?

Regeneron, Sanofi Get FDA Approval For Dupixent in Skin Disease CSU

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Mastek March-Quarter Consol Net Profit 810.7 Million Rupees

BiomX (PHGE) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term

TSX Penny Stock Highlights Calfrac Well Services And Two More Compelling Picks